ClinicalTrialsFinder

Invasive Carcinoma of the Breast Clinical Trials in Cary, North Carolina

1 recruitingCary, North Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Breast CancerHER2-positive Breast CancerInvasive Carcinoma of the Breast+2 more
Dana-Farber Cancer Institute375 enrolled32 locationsNCT04569747